老年癌症患者的药物治疗方案复杂性和再入院情况
Aslınur Albayrak1, Tuğçe Yaka2, Nurgül Yaşar3
1Department of Clinical Pharmacy, Faculty of Pharmacy, Suleyman Demirel University, Isparta, Türkiye.
概括
老年癌症患者的高药物复杂性与医院再入院的增加有关. 简化药物治疗方案可能会降低这种脆弱人群的再接收风险.
科学领域:
- 老年瘤学 老年瘤学
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 药物复杂性,受药物数量,频率和形式的影响,与住院和不合规等不良结果有关.
- 对老年癌症患者药物复杂性的研究是有限的,这凸显了对这种人口群体的影响理解的差距.
研究的目的:
- 评估药物治疗方案复杂性指数 (MRCI) 评分和老年癌症患者的30/90天再入院之间的关联.
- 确定有助于该患者群体MRCI得分的风险因素.
主要方法:
- 这是一项对65岁以上的癌症患者进行的回顾性研究,这些患者在2022年6月至2023年11月期间住院治疗.
- 利用药物治疗方案复杂性指数 (MRCI) 来量化药物治疗方案的复杂性.
- 使用后勤回归模型分析了MRCI和医院再入院之间的关联.
主要成果:
- 药物的中位数为6种,多药率为79.6%.
- 中位数MRCI得分为24分. 较高的MRCI得分是由药物的总数和患者年龄预测的.
- MRCI得分与30天和90天内重新入院的可能性有显著的关联.
结论:
- 用MRCI测量的药物复杂性是与老年癌症患者的再入院相关的重要因素.
- 旨在减少药物复杂性的干预措施可能是一个有价值的策略,以改善这一群体的结果并减少医疗保健使用率.
相关概念视频
Drug Dosing: Geriatric Patients
328
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
328
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
288
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
288
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
273
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
273
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
303
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
303
Drug Dosage Regimen: Overview
4.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.6K
Dosage Regimens: Designs and Approaches
402
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
402
